Recent Finacing
Recent Raise
Rejuvenation Technologies develops telomerase mRNA therapeutics delivered via tissue-targeted lipid nanoparticles to lung and liver, pursuing IND-enabling studies for pulmonary and hepatic fibrosis while scaling manufacturing and clinical operations.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
